Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Phenotype-by-phenome-wide association study of treatment resistant depression

View ORCID ProfileBrandon J Coombes, Jorge A Sanchez Ruiz, Brian Fennessy, View ORCID ProfileVanessa Pazdernik, Prakash Adekkanattu, Nicolas A Nunez, View ORCID ProfileLauren Lepow, View ORCID ProfileEuijung Ryu, Ardesheer Talati, Greg D Jenkins, Richard Pendegraft, Priya Wickramaratne, View ORCID ProfileJ John Mann, Mark Olfson, View ORCID ProfileMyrna M Weissman, View ORCID ProfileJyotishman Pathak, View ORCID ProfileAlexander W Charney, View ORCID ProfileJoanna M Biernacka
doi: https://doi.org/10.1101/2022.08.23.22279074
Brandon J Coombes
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brandon J Coombes
  • For correspondence: coombes.brandon{at}mayo.edu biernacka.joanna{at}mayo.edu
Jorge A Sanchez Ruiz
2Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Fennessy
3Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa Pazdernik
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vanessa Pazdernik
Prakash Adekkanattu
4Department of Population Health Sciences, Weill Cornell Medicine, New York, NY
5Clinical and Translational Science Center, Weill Cornell Medicine, New York, NY
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas A Nunez
2Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Lepow
6Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lauren Lepow
Euijung Ryu
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Euijung Ryu
Ardesheer Talati
7Department of Psychiatry, Columbia University & NY State Psychiatric Institute, New York, NY
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg D Jenkins
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Pendegraft
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priya Wickramaratne
7Department of Psychiatry, Columbia University & NY State Psychiatric Institute, New York, NY
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J John Mann
7Department of Psychiatry, Columbia University & NY State Psychiatric Institute, New York, NY
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J John Mann
Mark Olfson
7Department of Psychiatry, Columbia University & NY State Psychiatric Institute, New York, NY
MD MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myrna M Weissman
7Department of Psychiatry, Columbia University & NY State Psychiatric Institute, New York, NY
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Myrna M Weissman
Jyotishman Pathak
4Department of Population Health Sciences, Weill Cornell Medicine, New York, NY
8Department of Psychiatry, Weill Cornell Medicine, New York, NY
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jyotishman Pathak
Alexander W Charney
3Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
6Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY
9Mount Sinai Clinical Intelligence Center, Icahn School of Medicine at Mount Sinai, New York, NY
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander W Charney
Joanna M Biernacka
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
2Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joanna M Biernacka
  • For correspondence: coombes.brandon{at}mayo.edu biernacka.joanna{at}mayo.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective Treatment-resistant depression (TRD), defined as inadequate response to at least one or at least two antidepressant (AD) trials, is common in major depressive disorder (MDD). In this study, electronic health records (EHR) were used to identify clinical associations with TRD.

Methods Using two biobanks, phenomes of patients with at least one MDD-related diagnostic code and one AD prescription (N=17,049) were generated using aggregated diagnostic codes (phecodes) from EHRs. Phenotype-by-phenome-wide association analyses were performed for two binary definitions of TRD, based on either one or more, or two or more, AD switches after at least 30 days but within 14 weeks, and a quantitative measure defined as the number of unique ADs prescribed for at least 30 days.

Results Of the 17,049 patients with MDD, 1624 (9.5%) had at least one switch, 422 (2.5%) had at least two switches, and the number of unique antidepressant prescriptions ranged from one to twelve. After accounting for multiple testing, 142, 18, and 7 phecodes were significantly associated with the quantitative definition and the two binary definitions (≥1 AD switch or ≥2 AD switches), respectively. All three outcomes were significantly associated with known TRD risk factors including anxiety disorders, insomnia, and suicidal ideation. The quantitative measure was uniquely associated with other conditions including irritable bowel syndrome and decreased white blood cell count.

Conclusions In addition to identifying known clinical associations, the quantitative measure of treatment resistance uncovered new factors potentially associated with TRD. This measure may also facilitate discovery of genetic correlates of TRD in future analyses.

Competing Interest Statement

In the last three years, Dr. Weissman has received research funds from NIMH, Templeton Foundation, Brain and Behavior and the Sackler Foundation and has received royalties for publications of books on interpersonal psychotherapy from Perseus Press, Oxford University Press, on other topics from the American Psychiatric Association Press and royalties on the social adjustment scale from MultiHealth Systems. None of these represent a conflict of interest and all other authors have no other disclosures

Funding Statement

This study was supported by the National Institute of Mental Health (NIMH) grants: R01MH121924, R01MH121923, R01MH121922, and R01MH121921.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The current study was reviewed and approved by each site's Institutional Review Board and exempted from informed consent requirements as non-human subjects research: Mayo Clinic IRB approval 19-006227 and Mount Sinai IRB approval 07-0529.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Disclosures: In the last three years, Dr. Weissman has received research funds from NIMH, Templeton Foundation, Brain and Behavior and the Sackler Foundation and has received royalties for publications of books on interpersonal psychotherapy from Perseus Press, Oxford University Press, on other topics from the American Psychiatric Association Press and royalties on the social adjustment scale from MultiHealth Systems. None of these represent a conflict of interest and all other authors have no other disclosures

Data Availability

All data produced in the present study are only available after institutional review of request of access to the electronic health record.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 24, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Phenotype-by-phenome-wide association study of treatment resistant depression
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Phenotype-by-phenome-wide association study of treatment resistant depression
Brandon J Coombes, Jorge A Sanchez Ruiz, Brian Fennessy, Vanessa Pazdernik, Prakash Adekkanattu, Nicolas A Nunez, Lauren Lepow, Euijung Ryu, Ardesheer Talati, Greg D Jenkins, Richard Pendegraft, Priya Wickramaratne, J John Mann, Mark Olfson, Myrna M Weissman, Jyotishman Pathak, Alexander W Charney, Joanna M Biernacka
medRxiv 2022.08.23.22279074; doi: https://doi.org/10.1101/2022.08.23.22279074
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Phenotype-by-phenome-wide association study of treatment resistant depression
Brandon J Coombes, Jorge A Sanchez Ruiz, Brian Fennessy, Vanessa Pazdernik, Prakash Adekkanattu, Nicolas A Nunez, Lauren Lepow, Euijung Ryu, Ardesheer Talati, Greg D Jenkins, Richard Pendegraft, Priya Wickramaratne, J John Mann, Mark Olfson, Myrna M Weissman, Jyotishman Pathak, Alexander W Charney, Joanna M Biernacka
medRxiv 2022.08.23.22279074; doi: https://doi.org/10.1101/2022.08.23.22279074

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)